Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in ≥2nd Line Cetuximab-Based Therapy of Colorectal Cancer Patients
2011

Impact of Genetic Mutations and Skin Rash on Colorectal Cancer Treatment

Sample size: 112 publication 10 minutes Evidence: moderate

Author Information

Author(s): Saridaki Zacharenia, Tzardi Maria, Papadaki Chara, Sfakianaki Maria, Pega Fraga, Kalikaki Aristea, Tsakalaki Eleftheria, Trypaki Maria, Messaritakis Ippokratis, Stathopoulos Efstathios, Mavroudis Dimitris, Georgoulias Vassilis, Souglakos John

Primary Institution: University of Crete

Hypothesis

The study investigates the predictive significance of various genetic mutations and skin rash in metastatic colorectal cancer patients treated with cetuximab-based therapy.

Conclusion

KRAS and BRAF mutations, along with EREG expression, can serve as important biomarkers for selecting patients for anti-EGFR treatment in metastatic colorectal cancer.

Supporting Evidence

  • Patients with KRAS mutations had significantly lower time to tumor progression and overall survival.
  • BRAF mutations were associated with worse outcomes in metastatic colorectal cancer.
  • EREG and AREG expression levels correlated with treatment response.
  • Skin rash severity was linked to better treatment outcomes.

Takeaway

This study found that certain gene changes in cancer can help doctors decide which patients will benefit from a specific cancer treatment, and having a skin rash during treatment might also be a good sign.

Methodology

The study analyzed primary tumors from 112 metastatic colorectal cancer patients, assessing genetic mutations and skin toxicity during treatment.

Potential Biases

Potential biases may arise from the retrospective nature of the study and selection of patients.

Limitations

The study is retrospective and may not account for all variables affecting treatment outcomes.

Participant Demographics

The median age of participants was 66 years, with 60% male and 40% female.

Statistical Information

P-Value

p=0.001

Confidence Interval

95% CI 4.1–5.7

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1371/journal.pone.0015980

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication